The Independent Voice of
European Private Equity

Advanced Search

Inflexion-backed CNX Therapeutics acquires two medicines

Xhulio Ismalaj 2 April 2024

Inflexion-backed CNX Therapeutics has acquired two CNS products from Eisai, the French sales subsidiary of international pharmaceutical company Eisai Co, for €56.5m, excluding

Next article »

« Previous article

Related Articles

Deal originators part two: crafting a successful buy-and-build

09/05/24

CVC picks up minority stake in coatings supplier Hempel

09/05/24

MML Enterprise backs UK-based financial services compliance firm Cosegic

09/05/24

Cap10 appoints new partner

09/05/24

Mutares sells auto and industrial engineering service provider Iinovis

09/05/24

Investcorp closes fifth tech fund above target on $570m

09/05/24